Literature DB >> 7513839

Substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity (-LI) in rat knee joint synovial fluid during acute monoarthritis is not correlated with concentrations of neuropeptide-LI in cerebrospinal fluid and plasma.

I Bileviciute1, T Lundeberg, A Ekblom, E Theodorsson.   

Abstract

In a recent study we have shown a bilateral release of substance P (SP)-, neurokinin A (NKA)-, calcitonin gene-related peptide (CGRP)- and neuropeptide Y (NPY)-like immunoreactivity (-LI) in rat synovial fluid during acute monoarthritis. In order to elucidate the mechanisms underlying these phenomena, we examined the correlation between neuropeptide-LI in rat cerebrospinal fluid (CSF) and synovial fluid and between plasma and synovial fluid following the intra-articular injection of equal volumes (0.05 ml) of either Freund's adjuvans, carrageenan 2%, substance P 10(-5) M or human recombinant interleukin-1 alpha. Control rats were given saline intra-articularly. CSF, plasma and synovial fluid from the knee joints were obtained at 2, 6 and 24 h after injection and were analysed by specific radioimmunoassays. The intra-articular injection of pro-inflammatory substances induced changes in neuropeptide-LI in synovial fluid, CSF and plasma. However, there was no correlation between neuropeptide-LI in synovial fluid and plasma or between synovial fluid and CSF. The results of the present study does not support the hypothesis that the bilateral changes in neuropeptide-LI in synovial fluid were due to a release of neuropeptides from the inflamed joint into the systemic circulation. However, in carrageenan induced inflammation there was a tendency towards a correlation in SP-LI between CSF and synovial fluid suggesting that central neurogenic mechanisms should be studied in order to explain the bilateral changes seen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513839     DOI: 10.1016/0304-3940(94)91048-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  The role of histamine in neurogenic inflammation.

Authors:  A C Rosa; R Fantozzi
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

2.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

3.  Excitatory amino acid profiles of synovial fluid from patients with arthritis.

Authors:  T McNearney; D Speegle; N Lawand; J Lisse; K N Westlund
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

4.  An experimental study of the neurogenic and the immunological contribution to "tennis elbow" in rats.

Authors:  E Haker; E Theodorsson; T Lundeberg
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

Review 5.  Mast cell-neural interactions contribute to pain and itch.

Authors:  Kalpna Gupta; Ilkka T Harvima
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

6.  Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors.

Authors:  A J Davis; M N Perkins
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Neuropeptide gene expression and capsaicin-sensitive primary afferents: maintenance and spread of adjuvant arthritis in the rat.

Authors:  L F Donaldson; D S McQueen; J R Seckl
Journal:  J Physiol       Date:  1995-07-15       Impact factor: 5.182

8.  Intrathecal CGRP8-37-induced bilateral increase in hindpaw withdrawal latency in rats with unilateral inflammation.

Authors:  L C Yu; P Hansson; G Brodda-Jansen; E Theodorsson; T Lundeberg
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  Skin reaction to capsaicin in patients with systemic lupus erythematosus compared to healthy controls.

Authors:  Maryam Sahebari; Javad Salimi; Peyman Shalchian Tabrizi; Mina Khodabandeh; Nazila Ariaee Nasab; Masoumeh Salari
Journal:  Caspian J Intern Med       Date:  2021-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.